Schedule 13G ownership disclosure
Regen BioPharma Inc
Security class unavailable · CUSIP: 75886M201
Event date: 2020-03-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001078782-20-000148
- Form type
- SC 13G
- Filer
- LG CAPITAL FUNDING, LLC
- CIK
- CIK 1585346
- Filed
- Mar 03, 2020
- Reporting period
- Mar 03, 2020
- Description
- Schedule 13G beneficial ownership